Eugene

[email protected]

LATEST

Merck & Co.’s Chairman and CEO To Continue Past 2019
By

By
Merck & Co. announced that Kenneth C. Frazier, Chairman and Chief Executive Officer, has agreed to remain in his position beyond December 2019, when he turns 65. The company’s Board…

Alexion To Acquire Rare Disease Company in $1.2-Billion Deal
By

By
Alexion Pharmaceuticals, a Boston-headquartered pharmaceutical company, has agreed to acquire Syntimmune, a Boston, Massachusetts-based clinical-stage biopharmaceutical company developing antibody therapeutics targeting the neonatal Fc receptor (FcRn), in a deal worth…

MilliporeSigma Opens Lab for Biologics Services in Singapore
By

By
MilliporeSigma has opened a new $20-million 3,800-square-meter laboratory in Singapore for biologic testing services. The new lab complex involves the company’s BioReliance biosafety testing services as well as its M…

Gilead To Launch Authorized Generics of Top-Selling Hepatitis C Drugs
By

By
Gilead Sciences plans to launch in the US authorized generic versions of its two top-selling treatments for chronic hepatitis C virus (HCV), Epclusa (sofosbuvir 400 mg/velpatasvir 100 mg) and Harvoni…

Lonza Invests $414 Million to Expand Biomanufacturing Services
By

By
Lonza has invested CHF 400 million ($414 million) to add two new biomanufacturing services (Ibex Design and Ibex Develop) as part of its Ibex Solutions package from the company’s 100,000-square…

AGC Biologics To Build New Mfg Facility in Japan
By

By
AGC Biologics, a Bothell, Washington-headquartered contract development and manufacturing organization of biologics, plans to establish a new process development and manufacturing facility at its facility in Chiba, Japan. This move…

Allergan Plans to Build First Medical Aesthetics Center in China
By

By
Allergan plans to open its first Medical Aesthetics Innovation Center in Chengdu, China in early 2019. The center will have a training center for medical aesthetics healthcare professionals as well…

Almirall Acquires Allergan Dermatology Products for $550 Million
By

By
Almirall (ALM), a Barcelona-based provider of medicines and medical devices, has closed a deal to acquire a portfolio of five products from Allergan’s US Medical Dermatology unit for approximately $550…

Novo Nordisk Creates Four R&D Centers; Plans Staff Reductions
By

By
Novo Nordisk has announced plans to restructure its research & development (R&D) organization to accelerate expansion and diversification of its pipeline across chronic diseases. To enable this increased biological and…

Evonik Completes $42-Million Contract Mfg Expansion
By

By
Evonik, a specialty and fine chemical producer, has completed a EUR 36-million ($42-million) expansion of its contract manufacturing capabilities in the US and Europe. A series of technologies, including high-potency…